Prognostic significance of lymphocyte reconstitution in the early phase after cord blood transplantation.

Szczegóły

Tytuł:: Prognostic significance of lymphocyte reconstitution in the early phase after cord blood transplantation.
Autorzy:: Yuasa M; Department of Hematology, Toranomon Hospital, Japan.
Asano-Mori Y; Department of Hematology, Toranomon Hospital, Japan.
Mitsuki T; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Yamaguchi K; Department of Hematology, Toranomon Hospital, Japan.
Kageyama K; Department of Hematology, Toranomon Hospital, Japan.
Kaji D; Department of Hematology, Toranomon Hospital, Japan.
Taya Y; Department of Hematology, Toranomon Hospital, Japan.
Nishida A; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Ishiwata K; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Takagi S; Department of Hematology, Toranomon Hospital, Japan.
Yamamoto H; Department of Hematology, Toranomon Hospital, Japan.
Yamamoto G; Department of Hematology, Toranomon Hospital, Japan.
Araoka H; Department of Infectious Disease, Toranomon Hospital, Japan.
Wake A; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Makino S; Department of Transfusion Medicine, Toranomon Hospital, Japan.
Koike Y; Department of Clinical Laboratory, Toranomon Hospital, Tokyo, Japan.
Uchida N; Department of Hematology, Toranomon Hospital, Japan.
Taniguchi S; Department of Hematology, Toranomon Hospital, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Źródło:: British journal of haematology [Br J Haematol] 2021 Apr; Vol. 193 (2), pp. 423-427. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:: Letter
Język:: English
Imprint Name(s):: Publication: Oxford : Wiley-Blackwell
Original Publication: Oxford : Blackwell Scientific Publications
MeSH Terms:: Bone Marrow Transplantation/*adverse effects
Cord Blood Stem Cell Transplantation/*adverse effects
Immune Reconstitution/*immunology
Lymphocytes/*cytology
Bone Marrow Transplantation/methods ; Bone Marrow Transplantation/statistics & numerical data ; Case-Control Studies ; Cord Blood Stem Cell Transplantation/methods ; Cord Blood Stem Cell Transplantation/statistics & numerical data ; Flow Cytometry/methods ; Graft vs Host Disease/epidemiology ; Humans ; Incidence ; Kinetics ; Lymphocyte Count/statistics & numerical data ; Lymphocyte Count/trends ; Lymphocytes/immunology ; Prognosis ; Recurrence ; Retrospective Studies ; Survival Analysis ; Unrelated Donors
References:: Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood. 2010;115:3861-8.
Bejanyan N, Brunstein CG, Cao Q, Lazaryan A, Luo X, Curtsinger J, et al. Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD. Blood Adv. 2018;2:909-22.
Kanda J, Chiou LW, Szabolcs P, Sempowski GD, Rizzieri DA, Long GD, et al. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18:1664-76.
Politikos I, Lavery JA, Hilden P, Cho C, Borrill T, Maloy MA, et al. Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin. Blood Adv. 2020;4:191-202.
Magenau JM, Qin X, Tawara I, Rogers CE, Kitko C, Schlough M, et al. Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biol Blood Marrow Transplant. 2010;16:907-14.
Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J, et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood. 2006;108:1291-7.
Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J, et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest. 2010;120:1479-93.
Latis E, Michonneau D, Leloup C, Varet H, Peffault de Latour R, Bianchi E, et al. Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD. Blood Adv. 2020;4:3927-42.
Schultz KR, Kariminia A, Ng B, Abdossamadi S, Lauener M, Nemecek ER, et al. Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies. Blood. 2020;135:1287-98.
Entry Date(s):: Date Created: 20210322 Date Completed: 20210924 Latest Revision: 20210924
Update Code:: 20240105
DOI:: 10.1111/bjh.17376
PMID:: 33751547
: Opinia redakcyjna

Full Text Finder

Informacja